OpenBind's first data and model release marks a milestone for AI enabled drug discovery

The UK-led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset and ...
Drug Target Review

The scale divide: competing strategies in AI drug discovery

Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

How Do You Characterize AI’s Contributions in Drug Discovery?

Opinion: As AI use becomes more frequent in the invention of new drugs, it’s important to determine how it affects who’s ...
The Scientist

Drug Discovery: From Target Identification to Clinical Candidate

Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...
Observer

Daphne Koller Wants to Fix Drug Discovery With A.I.—and Real Data

Daphne Koller, founder and CEO of Insitro, has secured major partnerships with pharmaceutical giants like Eli Lilly and Bristol Myers Squibb to advance A.I.-powered drug discovery. Courtesy of Insitro ...
Forbes

Drug Discovery Gets A Boost With AI

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...